NRG1 and breast carcinoma: Our observation of a positive correlation between ERBB4 mRNA levels and increased relapse-free patients’ survival in the luminal A subtype is in line with a previous study showing that the activation of ERBB4 signaling by NRG1 restrains the growth of breast cancer luminal cells (32).